Tech Center 1700 • Art Units: 1637 1653 1682 1798
This examiner grants 53% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18687661 | METHODS AND COMPOSITIONS FOR INDUCING FETAL HEMOGLOBIN, MODULATING ERYTHROID CELL LINEAGES, AND PERTURBING MEGAKARYOCYTE LINEAGES | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS VI, LLC |
| 18705735 | HYDROGEL STRUCTURES AND METHODS OF MAKING AND USE THEREOF | Non-Final OA | GEORGIA TECH RESEARCH CORPORATION |
| 18580417 | Methods and Model Systems for Assessing Therapeutic Properties of Candidate Agents and Related Computer Readable Media and Systems | Non-Final OA | The Regents of the University of California |
| 18255307 | AMNIOTIC MEMBRANE FOR MYOCARDIAL REPAIR | Non-Final OA | The Regents of the University of California |
| 18315370 | MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING | Non-Final OA | The Regents of the University of California |
| 17778393 | CULTURES OF AND METHODS OF MANUFACTURING SQUAMOUS CELL CARCINOMA CELLS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 16772865 | A METHOD FOR STABILIZING CELL CULTURE SYSTEMS USING AN AMPHIPHILIC GRAFT COPOLYMER AS CELL CULTURE REAGENT | Non-Final OA | BASF SE |
| 18561236 | MULTI-REGIONAL HUMAN NEURAL CIRCUITS IN ASSEMBLOIDS DERIVED FROM PLURIPOTENT STEM CELLS | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 16634076 | METHOD FOR ISOLATING EXTRACELLULAR VESICLE USING HYDROPHOBIC INTERACTION | Final Rejection | POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION |
| 18575437 | FLUID SHEAR STRESS FOR EX VIVO ACTIVATION OF IMMUNE EFFECTOR CELLS | Non-Final OA | Vanderbilt University |
| 18293040 | ENGINEERING AAV VECTORS WITH IMPROVED CNS TARGETING | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 18063001 | Engineered 3D-Printed Artificial Axons | Final Rejection | Massachusetts Institute of Technology |
| 17440618 | CONTROL OF NITROGEN FIXATION IN RHIZOBIA THAT ASSOCIATE WITH CEREALS | Final Rejection | Massachusetts Institute of Technology |
| 18437974 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC CEREBROVASCULAR DISEASE | Non-Final OA | Research & Business Foundation Sungkyunkwan University |
| 18568589 | PRE-EPICARDIAL CELLS AND USES THEREOF | Non-Final OA | The General Hospital Corporation |
| 17781279 | Nerve Xenografts and Related Methods | Non-Final OA | The General Hospital Corporation |
| 17394008 | MESENCHYMAL CELL-DERIVED EXOSOMES TO TREAT NEUROLOGICAL DISORDERS | Final Rejection | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
| 18687608 | COMPOSITIONS AND METHODS FOR CELL REPROGRAMMING | Non-Final OA | CORNELL UNIVERSITY |
| 17761879 | Cell Culture Media Tablets and Methods of Manufacture | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17776164 | MATRICES FOR CELL CULTURE | Final Rejection | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy